Showing results (551-560 of 831) with videos related to
Sort By:
Pageof 84
Cancer|June 5, 2003
Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinosideGuillermo Garcia-Manero, Moshe Talpaz, Francis J Giles, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Survival advantage with imatinib mesylate therapy in chronic-phase chronic myelogenous ;eukemia (CML-CP) after IFN-alpha failure and in late CML-CP, comparison with historical controlsHagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Ian W Flinn, et al.Blood|August 2, 2011
The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemiaJulia Hoellenriegel, Sarah A Meadows, Mariela Sivina, et al.Leukemia & Lymphoma|August 10, 2013
Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experienceOhad Benjamini, Hagop Kantarjian, Mary Beth Rios, et al.Leukemia & Lymphoma|June 11, 2014
Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysisMichelle L Poon, Patricia S Fox, Barry I Samuels, et al.Clinical Lymphoma, Myeloma & Leukemia|January 21, 2014
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemiaStefan Faderl, Kumudha Balakrishnan, Deborah A Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disordersAnne J Novak, Deanna M Grote, Steven C Ziesmer, et al.Blood|November 6, 2016
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemiaBing Cui, Emanuela M Ghia, Liguang Chen, et al.Cancer Genetics and Cytogenetics|December 16, 2010
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyNyla A Heerema, John C Byrd, Paola S Dal Cin, et al.Pageof 84